丹麦雷度 Radiometer   
作为危急症检测领域的领导者，丹麦雷度专注于为危急症检测中的每一环节提供技术先进的解决方案。其全方位的解决方案涵盖了血气分析，经皮检测及包括心脏、血凝、感染及妊娠标志物方面的免疫检测。

凭借我们快速精准的危急症诊断结果，医护人员能够做出及时有效的判断，并进一步在重症监护室（ICUs）、急诊（EDs）和手术室（Ors）等危急症检测部门改进病患关怀及优化病患流动管理。

雷度成立于1935年，总部位于丹麦的哥本哈根。作为血气检测的先驱，雷度于1954年推出了世界上第一台商用血气分析仪。

通过全资子公司和授权经销商，雷度为全球100多个国家提供产品和服务。雷度米特医疗设备（上海）有限公司作为丹麦雷度在中国大陆及港澳台地区的全资子公司。

雷度隶属于，集团总部拥有约48,000名员工，分布在全球50个公司(NYSE:DHR)。 
   

Radiometer is the world leader in the development, manufacture and distribution of technologically advanced critical care testing systems for blood gas, electrolytes and metabolites.

The company offers complete solutions to the complex process of blood gas analysis through the use of innovative instrumentation, sampling products and information technology, supported by world-class customer and technical support.

Radiometer’s blood gas testing solutions meet the needs of both the traditional central laboratory and the increasing number of point of care sites in today’s hospital environment.

Radiometer is owned by the Danaher Corporation.

Radiometer Pacific P/L

Radiometer Pacific is the Australasian market leader in the field of high technology medical instrumentation. Radiometer Pacific employs over 30 staff throughout Australia and New Zealand in sales and support for the products that we sell.

For more information about how Radiometer Pacific is organised, go to Group Structure.

For the history of Radiometer Pacific, go to History.

Our way: Red System

Radiometer's high-quality and cost-effective solutions for diagnosing critically ill patients are customized with the Red System, Radiometer's approach for analyzing individual hospitals' needs and tailoring optimized solutions for them. Read more about the Red System.